Bio Rad Laboratories Stock In The News
BIO Stock | USD 254.45 9.44 3.85% |
Our overall analysis of Bio Rad's news coverage and content from conventional and social sources shows investors' bearish mood towards Bio Rad Laboratories. The specific impact of Bio Rad news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Bio Rad's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Bio Rad headlines in addition to utilizing other, more conventional financial analysis modules. Check out Bio Rad Backtesting and Bio Rad Hype Analysis.
Bio |
Bio Rad Today Top News and Investor Outlook
Bio Rad Laboratories Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Bio and other traded companies coverage with news coverage. We help investors stay connected with Bio headlines for the 14th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Bio Stock performance. Please note that trading solely based on the Bio Rad Laboratories hype is not for everyone as timely availability and quick action are needed to avoid losses.
Bio Rad stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Bio earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Bio Rad that are available to investors today. That information is available publicly through Bio media outlets and privately through word of mouth or via Bio internal channels. However, regardless of the origin, that massive amount of Bio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Bio Rad news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bio Rad relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bio Rad's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bio Rad alpha.
Bio Largest EPS Surprises
Earnings surprises can significantly impact Bio Rad's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
1993-02-12 | 1992-12-31 | 0.07 | 0.06 | -0.01 | 14 | ||
1994-02-09 | 1993-12-31 | 0.09 | 0.13 | 0.04 | 44 | ||
1993-04-28 | 1993-03-31 | 0.1 | 0.14 | 0.04 | 40 | ||
1996-05-01 | 1996-03-31 | 0.34 | 0.39 | 0.05 | 14 | ||
1995-08-02 | 1995-06-30 | 0.22 | 0.27 | 0.05 | 22 | ||
1998-12-01 | 1998-09-30 | 0.14 | 0.08 | -0.06 | 42 |
Bio Rad Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Bio Rad Laboratories Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
11th of March 2025
Neurological Biomarkers Global Market Review 2020-2024 and Forecast to 2030, Featuring Ana... at globenewswire.com

10th of March 2025
Bio-Rad stock touches 52-week low at 248.05 amid market shifts - Investing.com India at news.google.com

6th of March 2025
Microplates Market to Reach USD 1,301.08 million by 2032, Growing at an 4.50 percent CAGR ... at finance.yahoo.com

4th of March 2025
OncoCyte Corporation Among Penny Stocks with Insider Buying in 2025 at finance.yahoo.com

3rd of March 2025
High-Throughput Screening Technology Analysis and Global Markets 2021-2024 2025-2029 with ... at globenewswire.com

27th of February 2025
Principal Financial Group Inc. Divests 234 Shares of Bio-Rad Laboratories, Inc. at kalkinemedia.com

26th of February 2025
Bio-Rad International Revenue Performance Explored at zacks.com

25th of February 2025
Capillary Electrophoresis Market Report 2025-2030, with Profiles of Bio-Rad Laboratories, ... at finance.yahoo.com

21st of February 2025
Bio Detectors and Accessories Market to Reach USD 52.9 Billion by 2032 SNS Insider at finance.yahoo.com

14th of February 2025
Dignify Therapeutics Highlights Clinical Development Plans at BIO CEO Investor Conference at prnewswire.com

4th of February 2025
Has BioRad Laboratories Outpaced Other Medical Stocks This Year at zacks.com

17th of January 2025
Is Adaptive Biotechnologies Stock Outpacing Its Medical Peers This Year at finance.yahoo.com
Bio Rad Investors Sentiment
The influence of Bio Rad's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Bio. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Bio Rad's public news can be used to forecast risks associated with an investment in Bio. The trend in average sentiment can be used to explain how an investor holding Bio can time the market purely based on public headlines and social activities around Bio Rad Laboratories. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Bio Rad's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Bio Rad's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Bio Rad's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Bio Rad.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bio Rad in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bio Rad's short interest history, or implied volatility extrapolated from Bio Rad options trading.
Check out Bio Rad Backtesting and Bio Rad Hype Analysis. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 5.412 | Earnings Share (65.35) | Revenue Per Share | Quarterly Revenue Growth (0.02) | Return On Assets |
The market value of Bio Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.